96 related articles for article (PubMed ID: 19903776)
1. Contribution of degradation products to the anticancer activity of curcumin.
Shen L; Ji HF
Clin Cancer Res; 2009 Nov; 15(22):7108; author reply 7108-9. PubMed ID: 19903776
[No Abstract] [Full Text] [Related]
2. Phase II trial of curcumin in patients with advanced pancreatic cancer.
Dhillon N; Aggarwal BB; Newman RA; Wolff RA; Kunnumakkara AB; Abbruzzese JL; Ng CS; Badmaev V; Kurzrock R
Clin Cancer Res; 2008 Jul; 14(14):4491-9. PubMed ID: 18628464
[TBL] [Abstract][Full Text] [Related]
3. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
4. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.
Li L; Braiteh FS; Kurzrock R
Cancer; 2005 Sep; 104(6):1322-31. PubMed ID: 16092118
[TBL] [Abstract][Full Text] [Related]
5. Curcumin: the story so far.
Sharma RA; Gescher AJ; Steward WP
Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.
Sharma RA; Euden SA; Platton SL; Cooke DN; Shafayat A; Hewitt HR; Marczylo TH; Morgan B; Hemingway D; Plummer SM; Pirmohamed M; Gescher AJ; Steward WP
Clin Cancer Res; 2004 Oct; 10(20):6847-54. PubMed ID: 15501961
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of curcumin for patients with pancreatic cancer.
Kanai M
World J Gastroenterol; 2014 Jul; 20(28):9384-91. PubMed ID: 25071333
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Kunnumakkara AB; Anand P; Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
[TBL] [Abstract][Full Text] [Related]
9. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells.
Sharma C; Kaur J; Shishodia S; Aggarwal BB; Ralhan R
Toxicology; 2006 Nov; 228(1):1-15. PubMed ID: 16996673
[TBL] [Abstract][Full Text] [Related]
10. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
[TBL] [Abstract][Full Text] [Related]
11. Multi-targeted therapy by curcumin: how spicy is it?
Goel A; Jhurani S; Aggarwal BB
Mol Nutr Food Res; 2008 Sep; 52(9):1010-30. PubMed ID: 18384098
[TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
[TBL] [Abstract][Full Text] [Related]
13. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
14. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
[TBL] [Abstract][Full Text] [Related]
15. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
16. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
Divya CS; Pillai MR
Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
[TBL] [Abstract][Full Text] [Related]
17. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B.
Bierhaus A; Zhang Y; Quehenberger P; Luther T; Haase M; Müller M; Mackman N; Ziegler R; Nawroth PP
Thromb Haemost; 1997 Apr; 77(4):772-82. PubMed ID: 9134658
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
20. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
